Following U.S. Stocks are among the “Most Active” Stocks in the course of recent trading session, Tuesday: Boston Scientific Corporation (NYSE:BSX), Micron Technology, Inc (NASDAQ:MU), Microsoft Corporation (NASDAQ:MSFT), Alcoa Inc (NYSE:AA)

• Boston Scientific Corporation (NYSE:BSX), with shares dwindled -1.02% is now trading at $17.42, hitting new 52-week high of $17.81. The Stock is active as 8.38M shares changed hands versus its average volume of 14.09M shares.

• Micron Technology, Inc (NASDAQ:MU), with shares declined -2.88% is now trading at $27.68. The Stock is active as 7.51M shares changed hands versus its average volume of 22.90M shares.

• Microsoft Corporation (NASDAQ:MSFT) with shares dipped -0.72% is now trading at $41.26. The Stock is active as 6.55M shares changed hands versus its average volume of 35.40M shares.

• Alcoa Inc (NYSE:AA) with shares dropped -1.13% is now trading at $13.14. The Stock is active as 6.43M shares changed hands versus its average volume of 22.83M shares.

Latest NEWS regarding these Stocks are depicted underneath:

Boston Scientific Company (NYSE:BSX)

Boston Scientific Comapny (BSX), has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN Left Atrial Appendage Closure Device. The WATCHMAN Device offers a new stroke risk reduction option for high-risk patients with non-valvular atrial fibrillation who are seeking an alternative to long-term warfarin therapy. The WATCHMAN Device will be made accessible to U.S. centers involved in our clinical studies and additional, specialized centers as physicians are trained on the implant procedure.

The WATCHMAN Device is indicated to reduce the risk of thromboembolism from the left atrial appendage in patients with non-valvular atrial fibrillation who are at raised risk for stroke and systemic embolism based on CHADS2 or CHA2DS2-VASc scores, are deemed by their physicians to be suitable for warfarin; and have an appropriate rationale to seek a non-pharmacologic alternative to warfarin, taking into account the safety and effectiveness of the device contrast to warfarin.

The FDA approval of the WATCHMAN Device is based on the robust WATCHMAN clinical program which comprises of numerous studies, with more than 2,400 patients and nearly 6,000 patient-years of follow-up. The WATCHMAN clinical program offered strong evidence that the WATCHMAN Device can be implanted safely and reduces the risk of stroke in eligible patients while enabling most patients to discontinue warfarin. Additionally, a meta-analysis of all of the randomized trial data demonstrated that while ischemic stroke reduction favored warfarin, the WATCHMAN Device offered patients with a comparable protection against all-cause stroke and statistically superior reductions in hemorrhagic stroke, disabling stroke, and cardiovascular death contrast to warfarin over long-term follow-up.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The corporation operates in three segments: Cardiovascular, Rhythm Administration, and MedSurg.

Micron Technology, Inc. (NASDAQ:MU)

Micron Technology, Inc. (MU), declared the availability of ultra reliable, ultra high-speed and ultra high-temperature parallel NOR Flash and low-power DDR4 (LPDDR4) DRAM to meet the increasing memory requirements for the automotive market segment. Micron`s G18 NOR family offers the industry`s highest-performance parallel NOR, while Micron`s automotive-grade LPDDR4 solutions are an industry-first.

These new products meet the needs of automotive applications that require ultra high speed. The G18 family`s high performance (266 MB/s) enables faster boot and code execution for higher-density applications, while LPDDR4 enables 33 percent higher peak bandwidth than DDR4. Additionally, Micron`s new solutions deliver long-lasting reliability and meet ISO/TS certification requirements-with the G18 family enabling three times faster throughput over quad SPI NOR, and the LPDDR4 products undergoing additional package-level burn-in testing. Furthermore, Micron`s G18 NOR products have options that meet the industrial temperature (IT) range of -40 to 85°C and the automotive-grade automotive temperature (AAT) range of -40 to 105°C. The LPDDR4 products have options that meet the automotive-grade industrial temperature (AIT) range of -40 to 95°C, in addition to some future options that will meet the automotive-grade ultra temperature (AUT) range of -40C to 125°C, which is the highest operating temperature range in the industry, predictable to be accessible in 2016.

Micron Technology, Inc., is a global leader in advanced semiconductor systems. Micron`s broad portfolio of high-performance memory technologies-counting DRAM, NAND and NOR Flash-is the basis for solid state drives, modules, multichip packages and other system solutions.

Microsoft Corporation (NASDAQ:MSFT)

On Tuesday, At Microsoft Convergence 2015, Microsoft Corporation (MSFT), declared several new partnerships with industry leaders that will assist businesses enable data culture within their organizations and provide critical insights to assist deliver amazing experiences to their customers.

Teaming up with Microsoft, Ford Motor Co. will expand connected services for customers around the world with the creation of the Ford Service Delivery Network, powered by the scalable and reliable Microsoft Azure cloud computing platform. Ford and Lincoln owners will benefit from the convenience of new connectivity services that keep them better informed and in control of their vehicles at all times. Building the cloud-based Ford Service Delivery Network on the Azure platform enables Ford to quickly bring new connected features to market, quickly scale up global availability and provide flexibility for future customer offerings.

Microsoft and FieldOne Systems on Tuesday declared their contract to bring the FieldOne Sky field service administration solution into the Microsoft Dynamics global independent software vendor program. FieldOne Sky offers customers a holistic solution to enterprise field service organizations, addressing Microsoft Dynamics CRM customers’ planned business objectives to provide a world-class customer experience in the field while maximizing operational efficiency and mobile workforce productivity.

Deepening a planned partnership with DocuSign Inc., Microsoft declared that the two companies will bring DocuSign’s Digital Transaction Administration (DTM) platform to Microsoft Dynamics CRM users around the world. The partnership will assist Microsoft Dynamics CRM customers leverage these digital capabilities to assist sales teams close deals more quickly, easily and securely in the cloud for faster speed to proceed and a better customer experience.

Microsoft also declared the attainment of intellectual property from Fusion Software Inc., which will add Voice of the Customer capabilities to Microsoft Dynamics CRM. The new capabilities will comprise rule-based, multichannel feedback capabilities, allowing users the ability to comprise customer feedback directly into service, sales and marketing engagements.

Founded in 1975, Microsoft (NASDAQ:MSFT) is the worldwide leader in software, services, devices and solutions that assist people and businesses realize their full potential.

Alcoa Inc. (NYSE:AA)

Formerly on March 9, Alcoa Inc. (AA), declared another major milestone in its transformation, further building its value-add portfolio for profitable growth. The Corporation has signed a definitive contract to attain RTI International Metals, Inc. (RTI), a global supplier of titanium and specialty metal products and services for the commercial aerospace, defense, energy and medical device markets. Alcoa will purchase RTI in a stock-for-stock transaction with an enterprise value of $1.5 billion.

With RTI, Alcoa will grow its value-add businesses and further strengthen its aerospace portfolio. RTI will expand Alcoa’s range of titanium offerings and add advanced technologies and materials, increasing the Corporation’s position as a leading industrial innovator.

“Alcoa is accelerating its value-add growth engine by acquiring titanium leader RTI,” said Klaus Kleinfeld, Alcoa Chairman and Chief Executive Officer. “We are combining two innovators in materials science and process technology, shifting Alcoa’s transformation into a higher gear. RTI expands our aerospace portfolio market reach and positions us to capture future growth to deliver compelling value for customers, shareholders and employees.”

“Innovation and scale are critical to winning in both the titanium and aerospace industries recently, which is why this transaction is such a natural planned fit for both RTI and Alcoa,” said Dawne Hickton, Vice Chair, President and Chief Executive Officer of RTI International Metals. “We are happy to have an contract with Alcoa that delivers immediate value to our shareholders that appropriately reflects the strength of our business. Through this combination of forces, RTI will take its innovative technologies to the next level and deliver even more value-add titanium solutions to meet customer needs. We look forward to ongoing to accelerate RTI’s success as a part of the Alcoa team.”

Under the terms of the contract, Alcoa will attain all outstanding shares of RTI in a stock-for-stock transaction. RTI shareholders will receive 2.8315 Alcoa shares for each RTI share, representing a value of $41 per RTI share based on Alcoa’s closing price on March 6, 2015. The transaction has an enterprise value of $1.5 billion, counting $330 million of RTI cash on hand and up to $517 million in RTI’s convertible notes.

Alcoa Inc. produces and manages primary aluminum, fabricated aluminum, and alumina worldwide. The corporation operates through four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.